The Impact of Giant Cell Arteritis (GCA) Study

• Research type

  Research Study

• Full title

  The Impact of Giant Cell Arteritis (GCA) Study

• IRAS ID

  164056

• Contact name

  Jacqueline Gray

• Contact email

  j.gray@keele.ac.uk

• Sponsor organisation

  Arthritis Research UK Primary Care Centre, Keele University

• Duration of Study in the UK

  0 years, 3 months, 30 days

• Research summary

  Giant Cell Arteritis (GCA) is the commonest large-vessel vasculitis of older adults (>=50 years) and affects branches of the external carotid, ciliary and retinal arteries. If left untreated permanent loss of vision can occur. Early recognition is critical to prevent visual loss, that otherwise occurs in up to 20% of cases. Once high-dose corticosteroids are started, visual loss is rare. To date, little is known about the long term impact of GCA particularly within the primary care setting. This project aims to investigate the health care processes and health status outcomes of primary care patients with GCA using a cross-sectional questionnaire and linked retrospective medical record review.

• REC name

  West Midlands - South Birmingham Research Ethics Committee

• REC reference

  14/WM/1205

• Date of REC Opinion

  23 Oct 2014

• REC opinion

  Favourable Opinion